A role of the Duffy antigen for the maintenance of plasma chemokine concentrations

Biochemical and Biophysical Research Communications

Volumn 303, Issue 1, 2003, Pages 137-139

  Fukuma, Nobuko ^a   Akimitsu, Nobuyoshi ^a   Hamamoto, Hiroshi ^a   Kusuhara, Hiroyuki ^a   Sugiyama, Yuichi ^a   Sekimizu, Kazuhisa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHEMOKINE; DUFFY ANTIGEN; EOTAXIN; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; ALPHA CHEMOKINE; BETA CHEMOKINE; CARRIER PROTEIN; CELL SURFACE RECEPTOR; CHEMOTACTIC FACTOR; CXC CHEMOKINE IP 10; CXC CHEMOKINE IP-10; CXCL1 PROTEIN, MOUSE; DUFFY ANTIGEN BINDING PROTEIN, PLASMODIUM; PARASITE ANTIGEN; PROTOZOAL PROTEIN; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CLEARANCE; CONTROLLED STUDY; FEMALE; HALF LIFE TIME; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; ANIMAL; BLOOD; BLOOD GROUP DUFFY SYSTEM; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; TIME;

ANIMALS; ANTIGENS, PROTOZOAN; CARRIER PROTEINS; CHEMOKINES; CHEMOKINES, CC; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; DUFFY BLOOD-GROUP SYSTEM; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON TYPE II; MICE; MICE, KNOCKOUT; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; TIME FACTORS;

EID: 0037470778     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00293-6     Document Type: Article

References (15)

1. Rollins B.J., Chemokines Blood. 90:1997;909-928.
2. Clemons M.J., Marshall E., Durig J., Watanabe K., Howell A., Miles D., Earl H., Kiernan J., Griffiths A., Towlson K., DeTakats P., Testa N.G., Dougal M., Hunter M.G., Wood L.M., Czaplewski L.G., Millar A., Dexter T.M., Lord B.I. A randomized phase-II study of BB-10010 (macrophage inflammatory protein-1α) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy. Blood. 92:1998;1532-1540.
3. Kato Y., Sugiyama Y. Targeted delivery of peptides, proteins, and genes by receptor-mediated endocytosis. Crit. Rev. Ther. Drug Carrier Syst. 14:1997;287-331.
4. Laterveer L., Lindley I.J., Heemskerk D.P., Camps J.A., Pauwels E.K., Willemze R., Fibbe W.E. Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood. 87:1996;781-788.
5. Hepburn T.W., Hart T.K., Horton V.L., Sellers T.S., Tobia L.P., Urbanski J.J., Shi W., Davis C.B. Pharmacokinetics and tissue distribution of SB-251353, a novel human CXC chemokine, after intravenous administration to mice. J. Pharmacol. Exp. Ther. 298:2001;886-893.
6. Olszyna D.P., Jonge E.D., Dekkers P.E.P., Deventer S.J.H., Poll T. Induction of cell-associated chemokines after endotoxin administration to healthy humans. Infect. Immun. 69:2001;2736-2738.
7. Darbonne W.C., Rice G.C., Mohler M.A., Apple T., Hebert C.A., Valente A.J., Baker J.B. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J. Clin. Invest. 88:1991;1362-1369.
8. Neote K., Darbonne W., Ogez J., Horuk R., Schall T.J. Identification of a promiscuous inflammatory peptide receptor on the surface of red cells. J. Biol. Chem. 268:1993;12247-12249.
9. Szabo M.C., Soo K.S., Zlotnik A., Schall T.J. Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor. J. Biol. Chem. 270:1995;25348-25351.
10. Chaudhuri A., Zbrzezna V., Polyakova J., Pogo A.O., Hesselgesser J., Horuk R. Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor. J. Biol. Chem. 269:1994;7835-7838.
11. Neote K., Mak J.Y., Kolakowski L.F., Schall T.J. Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood. 84:1994;44-52.
12. Luo H., Chaudhuri A., Johnson K.R., Neote K., Zbrzezna V., He Y., Pogo A.O. Cloning, characterization, and mapping of a murine promiscuous chemokine receptor gene: homolog of the human Duffy gene. Genome Res. 7:1997;932-941.
13. Dawson T.C., Lentsch A.B., Wang Z., Cowhig J.E., Rot A., Maeda N., Peiper S.C. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood. 96:2000;1681-1684.
14. Luo H., Chaudhuri A., Zbrzezna V., He Y., Pogo A.O. Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol. Cell. Biol. 20:2000;3097-30101.
15. Oliva A., Kinter A.L., Vaccarezza M., Rubbert A., Catanzaro A., Moir S., Monaco J., Ehler L., Mizell S., Jackson R., Li Y., Romano J.W., Fauci A.S. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J. Clin. Invest. 102:1998;223-231.